Ron Best
Director/Board Member at The Victorian Health Promotion Foundation
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Frank Condella | M | 70 | 6 years | |
| Patrick Blake | M | 59 | 6 years | |
| Peter Gordon | M | - |
The Victorian Health Promotion Foundation
 The Victorian Health Promotion Foundation Advertising/Marketing ServicesCommercial Services The Victorian Health Promotion Foundation is a world-first health promotion foundation based in Carlton, Australia. The Australian company focuses on promoting good health and preventing chronic disease by conducting vital research and funding world-class interventions. The private company provides health promotion funding for sporting clubs, mental health organizations, and more. Additionally, they support the government's push for stronger regulations on e-cigarettes. The company offers health promotion programs, campaigns, and projects aimed at creating a healthier Victoria. The company also provides networking opportunities for researchers and connect research to policy and practice. The company's resource page for students undertaking unit 3 of Victorian Certificate of Education (VCE) Health and Human Development is also available. | 19 years |
| Bruce Robinson | M | 67 | 10 years | |
| Nicola Roxon | F | 57 |
The Victorian Health Promotion Foundation
The Victorian Health Promotion Foundation Advertising/Marketing ServicesCommercial Services The Victorian Health Promotion Foundation is a world-first health promotion foundation based in Carlton, Australia. The Australian company focuses on promoting good health and preventing chronic disease by conducting vital research and funding world-class interventions. The private company provides health promotion funding for sporting clubs, mental health organizations, and more. Additionally, they support the government's push for stronger regulations on e-cigarettes. The company offers health promotion programs, campaigns, and projects aimed at creating a healthier Victoria. The company also provides networking opportunities for researchers and connect research to policy and practice. The company's resource page for students undertaking unit 3 of Victorian Certificate of Education (VCE) Health and Human Development is also available. | - |
| Brant Schofield | M | - | 6 years | |
| Stephen Walter | M | - |
The Victorian Health Promotion Foundation
The Victorian Health Promotion Foundation Advertising/Marketing ServicesCommercial Services The Victorian Health Promotion Foundation is a world-first health promotion foundation based in Carlton, Australia. The Australian company focuses on promoting good health and preventing chronic disease by conducting vital research and funding world-class interventions. The private company provides health promotion funding for sporting clubs, mental health organizations, and more. Additionally, they support the government's push for stronger regulations on e-cigarettes. The company offers health promotion programs, campaigns, and projects aimed at creating a healthier Victoria. The company also provides networking opportunities for researchers and connect research to policy and practice. The company's resource page for students undertaking unit 3 of Victorian Certificate of Education (VCE) Health and Human Development is also available. | 11 years |
| Keith Moore | M | - | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Roger Aston | M | 68 |
Halcygen Pharmaceuticals Ltd.
 Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 7 years |
| Craig Bottomley | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Roger Corbett | M | 81 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| Aaron John Finlay | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 5 years |
| Bruce Mathieson | M | 80 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 3 years |
| Ian Scholes | M | 69 |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | 15 years |
| Stuart Mudge | M | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| Nancy Dolan | F | 72 | 6 years | |
| Peter Paltoglou | M | - | 7 years | |
| Nicholas Freeman | M | - | 3 years | |
| Scott Richards | M | 60 | 10 years | |
| Angelo Morella | M | - | - | |
| Mark Cansdale | M | - | 6 years | |
| William Hodges | M | 67 | 6 years | |
| Gina Greentree | F | - | 1 years | |
| Christelle Simpson | F | - | - | |
| Simone Parkes | F | - |
Halcygen Pharmaceuticals Ltd.
Halcygen Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Halcygen Pharmaceuticals Ltd. engages in development and licensing of new improved proprietary generic formulations known as Super Generics or High Functionality Generics. Halcygen Pharmaceuticals products includes: Suba Itraconazole is a super-bioavailable formulation of itraconazole, a synthetic broad-spectrum anti-fungal agent and Minocycline is used to treat bacterial infections including respiratory tract infections, infections of skin, genital and urinary systems. The company is headquartered in Melbourne, Australia. | - |
| Peter James Truelove | M | - | - | |
| Stefan J. Cross | M | 51 | 11 years | |
| Kate Hall | F | - | - | |
| Ilana Stancovski | M | - | - | |
| Danny Dragovic | M | - | - | |
| Andrew van Breugel | M | - | 2 years | |
| Craig Boyd | M | - | - | |
| Gadi Ben Nissim | M | - | 1 years | |
| Kimberly McClintock | F | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 34 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ron Best
- Personal Network
